The use of a common hormonal intra-uterine device for contraception is linked to a slightly elevated risk of breast cancer, a recent study revealed.
The researchers have found that Levonorgestrel-Releasing Intrauterine Systems (LNG-IUS) was linked to 14 extra cases of breast cancer per 10,000 women compared to those not using contraceptive medication in a study group of participants between the ages 15 and 49. However, the risk did not increase with the duration of use.
